Direct Allergy's Seed - IV Round

Direct Allergy raised a round of funding on September 17, 2015. Investors include Ben Franklin Technology Partners.

Direct Allergy provides a customized allergy treatment within a physician's office through immunotherapy, a therapeutic process developed to provide an allergy sufferer symptom relief. Through the cou…

Articles about Direct Allergy's Seed - IV Round: